Assessment of PLGA-PEG-PLGA copolymer hydrogel for sustained drug delivery in the ear

Current Drug Delivery

Volumn 11, Issue 2, 2014, Pages 279-286

  Feng, Liang ^a   Ward, Jonette A ^b   Li, S Kevin ^a   Tolia, Gaurav ^a   Hao, Jinsong ^c   Choo, Daniel I ^b,d  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c MARSHALL UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Auditory brainstem response; Cidofovir; Drug delivery; Ear; Hydrogel; Sustained release

Indexed keywords

CIDOFOVIR; COPOLYMER; GLYCEROL; POLOXAMER; POLY(LACTIC CO GLYCOLIC ACID) POLY(ETHYLENE GLYCOL) POLY(LACTIC CO GLYCOLIC ACID) COPOLYMER; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; HYDROGEL; MACROGOL DERIVATIVE; POLY(LACTIC-GLYCOLIC ACID)-POLY(ETHYLENEGLYCOL) COPOLYMER; POLYGLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG SAFETY; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; HEARING DISORDER; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; INNER EAR; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; SOLUBILITY;

ANIMALS; DELAYED-ACTION PREPARATIONS; EAR, INNER; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HYDROGEL; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; SOLUBILITY;

EID: 84930910441     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811666140118224616     Document Type: Article

References (22)

1. Swan, E.E.; Mescher, M.J.; Sewell, W.F.; Tao, S.L.; Borenstein, J.T. Inner ear drug delivery for auditory applications. Adv. Drug Deliv. Rev., 2008, 60, 1583-1599.
2. Piu, F.; Wang, X.; Fernandez, R.; Dellamary, L.; Harrop, A.; Ye, Q.; Sweet, J.; Tapp, R.; Dolan, D.F.; Altschuler, R.A.; Lichter, J.; LeBel, C. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol. Neurotol., 2011, 32, 171-179.
3. Salt, A.N.; Hartsock, J.; Plontke, S.; LeBel, C.; Piu, F. Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation. Audiol. Neu-rootol., 2011, 16, 323-335.
4. Wang, X.; Dellamary, L.; Fernandez, R.; Harrop, A.; Keithley, E.M.; Harris, J.P.; Ye, Q.; Lichter, J.; LeBel, C.; Piu, F. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiol. Neurootol., 2009, 14, 393-401.
5. Paulson, D.P.; Abuzeid, W.; Jiang, H.; Oe, T.; O'Malley, B.W.; Li, D. A novel controlled local drug delivery system for inner ear disease. Laryngoscope, 2008, 118, 706-711.
6. Borden, R.C.; Saunders, J.E.; Berryhill, W.E.; Krempl, G.A.; Thompson, D.M.; Queimado, L. Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane. Audiol. Neurootol., 2011, 16, 1-11.
7. Saber, A.; Laurell, G.; Bramer, T.; Edsman, K.; Engmer, C.; Ulfen-dahl, M. Middle ear application of a sodium hyaluronate gel loaded with neomycin in a Guinea pig model. Ear Hear., 2009, 30, 81-89.
8. Kelly, R.M.; Meyer, J.D.; Matsuura, J.E.; Shefter, E.; Hart, M.J.; Malone, D.J.; Manning, M.C. In vitro release kinetics of gentamy-cin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Dev. Ind. Pharm., 1999, 25, 15-20.
9. Horie, R.T.; Sakamoto, T.; Nakagawa, T.; Tabata, Y.; Okamura, N.; Tomiyama, N.; Tachibana, M.; Ito, J. Sustained delivery of li-docaine into the cochlea using poly lactic/glycolic acid microparti-cles. Laryngoscope, 2010, 120, 377-383.
10. Qiu, Y.; Park, K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev., 2001, 53, 321-339.
11. Shim, M.S.; Lee, H.T.; Shim, W.S.; Park, I.; Lee, H.; Chang, T.; Kim, S.W.; Lee, D.S. Poly(D,L-lactic acid-co-glycolic acid)-b-poly(ethylene glycol)-b-poly (D,L-lactic acid-co-glycolic acid) tri-block copolymer and thermoreversible phase transition in water. J. Biomed. Mater. Res., 2002, 61, 188-196.
12. Jeong, B.; Kim, S.W.; Bae, Y.H. Thermosensitive sol-gel reversible hydrogels. Adv. Drug Deliv. Rev., 2002, 54, 37-51.
13. Liu, H.; Feng, L.; Tolia, G.; Liddell, M.R.; Hao, J.; Li, S.K. Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing. Drug Dev. Ind. Pharm., (in press).
14. Qiao, M.; Chen, D.; Ma, X.; Liu, Y. Inject able biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the co-polymer-based hydrogels. Int. J. Pharm., 2005, 294, 103-112.
15. Jeong, B.; Choi, Y.K.; Bae, Y.H.; Zentner, G.; Kim, S.W. New biodegradable polymers for injectable drug delivery systems. J. Control. Release, 1999, 62, 109-114.
16. Chen, S.; Pieper, R.; Webster, D.C.; Singh, J. Triblock copolymers: synthesis, characterization, and delivery of a model protein. Int. J. Pharm., 2005, 288, 207-218.
17. Desai, S.D.; Blanchard, J. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J. Pharm. Sci., 1998, 87, 226-230.
18. Zhang, L.; Parsons, D.L.; Navarre, C.; Kompella, U.B. Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. J. Control. Release, 2002, 85, 73-81.
19. Shastri, D.H.; Prajapati, S.T.; Patel, L.D. Design and development of thermoreversible ophthalmic in situ hydrogel of moxifloxacin HCl. Curr. Drug Deliv., 2010, 7, 238-243.
20. Zentner, G.M.; Rathi, R.; Shih, C.; McRea, J.C.; Seo, M.H.; Oh, H.; Rhee, B.G.; Mestecky, J.; Moldoveanu, Z.; Morgan, M.; Weit-man, S. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J. Control. Release, 2001, 72, 203-215.
21. Rivera, T.; Sanz, L.; Camarero, G.; Varela-Nieto, I. Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss. Curr. Drug Deliv., 2012, 9, 231-242.
22. Nakagawa, T.; Ito, J. Local drug delivery to the inner ear using biodegradable materials. Ther. Deliv., 2011, 2, 807-814.